Echinacea angustifolia

Echinacea angustifolia

What the trials found

Echinacea angustifolia does not have enough research to establish easier cold symptoms or fewer colds and respiratory infections in adults.

  • 1 papers
  • 2 of 2 outcomes

Median effective dose, most-studied outcomes

Full protocol, 2 outcomes

Risk, worst reported severity

  • Gastrointestinal side effects

What echinacea angustifolia actually does

Outcome Effect Evidence Dose Time Rank
Early research 2
Feel less sick with a cold Not enough research Cold symptoms such as cough, congestion, and fever can make ordinary days harder.
trivial
1 RCT 1 papers · n=155 300 mg
Get fewer common infections Not enough research A respiratory, skin, or soft-tissue infection can interrupt work, school, and daily routines.
trivial
1 RCT 1 papers · n=155 300 mg

Effect tiers come from native-unit MCID where available, Cohen's d otherwise.

Protocol

Dose, timing & forms

How much

The limited trial evidence used 300 mg daily by mouth for cold symptoms and respiratory infection prevention, and it found no significant benefit.1 That means there is no evidence-based target dose to recommend for either preventing a cold or making one less severe.1

When and how long

The evidence does not establish a useful time of day, food rule, or start-at-the-first-sniffle strategy for Echinacea angustifolia.1 Taking it consistently does not substitute for evidence, since the studied approach did not produce meaningful respiratory benefits.1

Forms & standardisation

Look for a label that clearly names Echinacea angustifolia and identifies the plant part, especially root, rather than simply saying “echinacea.” The available clinical evidence is too limited to favor a specific extract type or alkylamide standardization level.1

Studied range, by outcome

Outcome Studied range Median effective Duration Evidence
Ease cold and flu symptoms 300 mg 1 paper
Prevent acute respiratory infections 300 mg 1 paper

Adverse events and drug interactions

Safety events

Gastrointestinal side effects
In context

What this is and how it works

  • One randomized trial (n=155) found no clear change in cold symptoms or respiratory infections 1.
  • One paper reviewed here spans two outcomes: cold-symptom relief and prevention of colds or respiratory infections.
  • Evidence comes from one small randomized trial, limiting confidence in both outcomes.

Echinacea angustifolia is a prairie flower native to North America. Its root has a long history in herbal products, usually sold as capsules, tablets, teas, or liquid extracts for cold-season support.

Echinacea angustifolia contains plant compounds called alkylamides, but the available clinical trial does not show that they create a meaningful change in the body that translates into fewer or easier colds.1 Think of the extract as a key ring with many keys: scientists have not identified one that reliably turns the immune response in a useful direction for cold symptoms.1

Bottom line

Echinacea angustifolia is not a strong pick if your goal is to prevent colds or noticeably reduce cold symptoms. One small trial found trivial, non-significant results, while digestive side effects remain possible.1

Frequently asked

Common questions

Does Echinacea angustifolia prevent colds?

It does not appear to prevent colds or acute respiratory infections based on the limited clinical evidence reviewed. The available trial found no meaningful benefit, so it is not a dependable prevention strategy.1

Can Echinacea angustifolia shorten a cold?

The available trial showed no meaningful improvement in cold symptoms. Early use is popular, but this evidence does not establish that Echinacea angustifolia makes a cold easier to manage.1

What side effects does Echinacea angustifolia cause?

Digestive upset is a reported concern. Stop using it if it makes you feel unwell, and check with a clinician before use if you have medical conditions or take regular medicines.1

Sources

Sources

  1. 1. Treatment of the common cold with unrefined Echinacea. A randomized, double-blind, placebo-controlled trial (2002)

Generated August 27, 2026